CULTURED AFB ANTITUBERCULAR DST RAPID 11 DRUGS PANEL Test
Test Cost: AED 2710.0
Components:
- Streptomycin
- Isoniazid
- Rifampicin
- Ethambutol
- Pyrazinamide
- Clofazimine
- Ethionamide
- Capreomycin
- Kanamycin
- Amikacin
- Ofloxacin
Price: 2710.0 AED
Sample Condition:
Submit pure growth of Mycobacterium tuberculosis complex on appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigerated OR when used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submitted will be processed for Antitubercular Sensitivity.
Report Delivery:
Sample daily by 3.30 pm; Report 21 days
Method:
Automated Fluorescent
Test Type:
Tuberculosis
Doctor:
Physician
Test Department:
Pre Test Information: No special preparation required
Test Details:
The CULTURED AFB ANTITUBERCULAR DST RAPID 11 DRUGS PANEL test is a diagnostic test used to determine the susceptibility of mycobacterial strains to various antitubercular drugs. It is primarily used for testing strains of Mycobacterium tuberculosis, the bacteria that causes tuberculosis. The test panel includes 11 different drugs commonly used in the treatment of tuberculosis, including isoniazid, rifampin, ethambutol, streptomycin, pyrazinamide, kanamycin, amikacin, capreomycin, moxifloxacin, ofloxacin, and ethionamide. These drugs belong to different classes and have different mechanisms of action against the bacteria. During the test, a culture of the mycobacterial strain is grown in the presence of the different drugs. The growth of the bacteria is then observed to determine if they are susceptible or resistant to each drug. This information helps guide the selection of appropriate drugs for the treatment of tuberculosis, as drug-resistant strains require different treatment regimens. The CULTURED AFB ANTITUBERCULAR DST RAPID 11 DRUGS PANEL test is important in the management of tuberculosis, as it helps healthcare providers choose the most effective treatment options for patients. It can also provide valuable information about the prevalence of drug-resistant strains in a particular population, which is important for public health planning and monitoring.
Test Name | CULTURED AFB ANTITUBERCULAR DST RAPID 11 DRUGS PANEL Test |
---|---|
Components | *Streptomycin*Isoniazid*Rifampicin *Ethambutol*Pyrazinamide *Clofazimine *Ethionamide*Capreomycin*Kanamycin *Amikacin *Ofloxacin |
Price | 2710.0 AED |
Sample Condition | Submit pure growth ofMycobacterium tuberculosis complexon appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigerated ORwhen used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submittedwill be processed for Antitubercular Sensitivity. |
Report Delivery | Sample Daily by 3.30 pm; Report 21 days |
Method | Automated Fluorescent |
Test type | Tuberculosis |
Doctor | Physician |
Test Department: | |
Pre Test Information | No special preparation required |
Test Details | The CULTURED AFB ANTITUBERCULAR DST RAPID 11 DRUGS PANEL test is a diagnostic test used to determine the susceptibility of mycobacterial strains to various antitubercular drugs. It is primarily used for testing strains of Mycobacterium tuberculosis, the bacteria that causes tuberculosis. The test panel includes 11 different drugs commonly used in the treatment of tuberculosis, including isoniazid, rifampin, ethambutol, streptomycin, pyrazinamide, kanamycin, amikacin, capreomycin, moxifloxacin, ofloxacin, and ethionamide. These drugs belong to different classes and have different mechanisms of action against the bacteria. During the test, a culture of the mycobacterial strain is grown in the presence of the different drugs. The growth of the bacteria is then observed to determine if they are susceptible or resistant to each drug. This information helps guide the selection of appropriate drugs for the treatment of tuberculosis, as drug-resistant strains require different treatment regimens. The CULTURED AFB ANTITUBERCULAR DST RAPID 11 DRUGS PANEL test is important in the management of tuberculosis, as it helps healthcare providers choose the most effective treatment options for patients. It can also provide valuable information about the prevalence of drug-resistant strains in a particular population, which is important for public health planning and monitoring. |